期刊文献+

32株纹带棒杆菌的感染及其耐药分析 被引量:1

Identification and Resistance Analysis of 32 Strains of Corynebacterium striatum Clinical Isolates
下载PDF
导出
摘要 目的了解纹带棒杆菌感染在临床标本中的分布以及药物敏感情况,指导临床用药。方法纹带棒杆菌的鉴定采用法国生物梅里埃公司API Coryne鉴定系统,用琼脂稀释法测定20种抗菌药物的最低抑菌浓度(MIC)。结果32株纹带棒杆菌主要标本来源为痰,ICU分离率最高;亚胺培南、万古霉素、利福平对该菌有较高的敏感性;阿米卡星、庆大霉素、妥布霉素、米诺环素等次之;而β-内酰胺酶及β-内酰胺酶加酶抑制剂的头孢哌酮/舒巴坦、哌拉西林/他唑巴坦对纹带棒杆菌有较高的MIC值。结论纹带棒杆菌在年龄大、免疫力低下人群中分离率高,呼吸机的使用与其感染密切相关;纹带棒杆菌对大多数抗菌药物耐药,属多药耐药菌株,亚胺培南、万古霉素、利福平为临床首选用药。 OBJECTIVE To analyze the results of antimicrobial susceptibility for clinically isolated Corynebacterzurn striatum strains and investigate the distribution of minimal inhibitory concentration (MIC) of the antibiotics commonly used in clinic against C. striatum. METHODS C. striatum was identified with API Coryne System (bioMerieux, France). Antimicrobial susceptibility test was conducted by agar dilution method. RESULTS MIC90 of imipenem, vancomycin and rifampin against C. striatum was 8, 0. 5 and 2 /μg/ml, and that of amikacin, gentamicin, tobramycin, and minocycline was 8 16μg/ml, but MICg0 of the other antibiotics was 32 -256 μg/ml. The main source of 32 isolates was from bronchofihroseopic secretion. CONCLUSIONS The activity of vancomycin, rifampin and imipenem against C. striatum shows stable susceptibility, but of amikacin, gentamicin, tobramycin and minocycline shows inferiority. However, the susceptibility to other antibiotics is low. So vaneomycin, rifampin and imipenem are the optimal antibiotics to treat the infections caused by C. striatum.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2008年第10期1454-1455,共2页 Chinese Journal of Nosocomiology
关键词 纹带棒杆菌 抗菌药物敏感性 最低抑菌浓度 Corynebacterium striatum Antimicrobial susceptibility Minimal inhibitory concentration
  • 相关文献

参考文献5

二级参考文献16

  • 1Patrick R..Murray,Ellen Jo Baron,Michael A.Pfaller,et al.Manual of Clinical Microbiology[M].Washington,DC:American Society for Microbiology Press,2003.472-496.
  • 2Otsuka Y.,Y Kawanmura,T Koyanm,et al.Cotynebaeterium reaisterns sp.nov.,a new multidrug-resistant coryneform bacterium isolated form human infections[J].J Clin Microbiol,2005.,43(8):3713.
  • 3Babay HA.,AM.Kambal.Isolation of coryneform bacteria from blood cultures of patients at a University Hospital in Saudi Arabia[J].J Saudi Med,2004,25(8):1073.
  • 4Ubaldi M NIL.D'Annibale MC,Medori,,et al.Coryneform bacteria:their clinical significance and resistance patterns during a three-year study[J].Infez Med,2004.12(2):126.
  • 5Balci I,F Eksi,A Bayram.Coryneform bacteria isolated from blood cultures and their antibiotic susceptibilities[J].J Int Med Res,2002,30(4):422.
  • 6Lagrou K,J Verhaegen,M Janssens,et al.Prospective study of catalase-positive coryneform organisms in clinical specimens:identification,clinical relevance,and antibiotic susceptibility[J].Diagn Microbiol Infect Dis,1998,30(1):7.
  • 7Khamis A,D Raoult,B La Scola.Comparison between rpoB and 16SrRNA Gene Sequencing for Molecular Identification of 168 Clinical Isolates of Corynebacterium[J].J Clin Microbiol,2005,43:1934.
  • 8Khamis A,D Raoult,B La Scola.rpoB gene sequencing for identification of Corynebacterium species[J].J Clin Microbiol,2004,42:3925.
  • 9Clinincal and laboratory standards institute.Performance standards for antimicrobial susceptibility testing;sixteenth informational supplement.2006,19.
  • 10Martinez-Martinez L,Joyanes P,Suarez AI,et al.Perea activities of gemifloxacin and five other antimicrobial agents against Listeria monocytogenes and Coryneform bacteria isolated from clinical samples[J].Antimcrob Agents Chemother,2001,45 (8):2390-2392.

共引文献14

同被引文献5

引证文献1

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部